Roivant Sciences (ROIV) Receivables (2021 - 2024)
Roivant Sciences (ROIV) posted Receivables of $678000.0 for Q4 2024, down 64.61% on a QoQ basis from $1.9 million in Q3 2024, and down 98.35% year-over-year from $41.1 million in Q1 2024.
Roivant Sciences (ROIV) Receivables (2021 - 2024) Analysis & Trends
Roivant Sciences' Receivables history runs 4 years deep, the most recent figure standing at $678000.0 for Q4 2024.
- Quarterly Receivables fell 98.35% year-over-year to $678000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $678000.0 (down 98.35% YoY) and the FY2024 annual result came in at $678000.0, down 98.35% from the prior year.
- Receivables was $678000.0 for Q4 2024 at Roivant Sciences, down from $1.9 million in the prior quarter.
- Across five years, Receivables topped out at $79.8 million in Q2 2024 and bottomed at $678000.0 in Q4 2024.
- A 4-year average of $22.5 million and a median of $11.2 million in 2021 frame the typical range for Receivables.
- Annual changes were most pronounced in 2023 — Receivables jumped 683.37% — and 2024, when it sank 98.35%.
- Roivant Sciences' Receivables stood at $8.9 million in 2021, then jumped by 213.5% to $28.0 million in 2022, then jumped by 46.88% to $41.1 million in 2023, then sank by 98.35% to $678000.0 in 2024.
- Business Quant data shows ROIV's Receivables at $678000.0 in Q4 2024, $1.9 million in Q3 2024, and $79.8 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 4.97 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 938.02 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.13 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Roivant Sciences | 24.35 Bn | 25.12 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 678,000.00 |
| Sep 30, 2024 | 1.92 Mn |
| Jun 30, 2024 | 79.79 Mn |
| Mar 31, 2024 | 3.99 Mn |
| Dec 31, 2023 | 41.08 Mn |
| Sep 30, 2023 | 52.12 Mn |
| Jun 30, 2023 | 37.06 Mn |
| Mar 31, 2023 | 30.38 Mn |
| Dec 31, 2022 | 27.97 Mn |
| Sep 30, 2022 | 25.04 Mn |
| Mar 31, 2022 | 3.88 Mn |
| Dec 31, 2021 | 8.92 Mn |
| Sep 30, 2021 | 9.81 Mn |
| Jun 30, 2021 | 3.42 Mn |
| Mar 31, 2021 | 11.22 Mn |